🔥RMANF - Mind Blowing Potential Play

[Image]( Greetings Traders, We have a brand-new alert for you tonight to put high on your watchlist! This is a company involved with something that could help millions of people battling depression, addiction, and many other disorders! The ticker is RMANF RMANF is currently trading around 5 cents but has a 52-week high of nearly 32 cents. It was also only this past August that RMANF share prices were at their 52-week high. This was not long ago! The fact that shares are around 5 cents now is also exciting because it was last week that they ran from $0.058 to $0.1182 overnight for a gain of over 100%! If more of Wall Street learns about this company, share prices could stand to see a big rebound and head back to previous highs. This could potentially mean some monstrous gains... While the world is focused on legal marijuana... there's another drug that could quickly hit the spotlight for all of its health benefits and RMANF is involved with it... This is one under the radar play worth reading about that is focused on a fast-growing niche industry that many aren't talking about! Hurry and read our exclusive report on the company below: Roadman Investment (OTC: RMANF) (TSXV: LITT) []( Roadman Investments (OTC: RMANF) (TSXV: LITT) is a Canadian venture capital and advisory firm that strives to actively drive innovation and accelerate growth within its portfolio holdings, with the objective of realizing alpha returns. The company is mandated with deploying investment capital and advisory services to both public and private companies. Its investment committee looks to identify companies with a strong potential for accretive revenue and profitability in the following sectors: - Agricultural - Financial Services - Technology - Health & Wellness It was only in August that RMANF completed a C$150,000.00 strategic investment in British Columbia-based craft mushroom distributor and product formulator Champignon Brands Inc. Champignon is a private, research-driven company specializing in the formulation and end distribution of a suite of premium artisanal mushroom health supplements, with the objective of promoting holistic health and wellness. The company is equipped with proprietary formulations for three flagship mushroom-extract-infused tea blends and is in the process of conducting extensive taste and product quality tests. Champignon’s flagship e-commerce store includes a selection of craft mushroom-infused teas and ancillary accessories, earmarked for worldwide distribution. The company is currently taking pre-orders for its flagship “Brain Enhance”, “Nourish Force”, “Mighty Re-charge” medicinal mushroom organic teas. The e-commerce store also carries a selection of tea accessories including tea pots, mugs and t-shirts. Luke Montaine, Chief Executive Officer and a Director of RMANF stated: “Roadman’s tactical deployment of capital into the burgeoning craft mushroom vertical is indicative of popular opinion shifting within the space." He continued, "On May 8th, 2019, Denver voters approved Initiative 301, a measure that prohibits the city’s government from deploying resources to impose criminal penalties relating to the consumption and possession of psilocybin by adults over 21 years of age. The passage of Initiative 301 comes amid a recent resurgence in the study of psilocybin and its potential medical applications. Researchers worldwide are increasingly examining whether psilocybin may alleviate symptoms associated with conditions such as anxiety, obsessive-compulsive disorder, major depressive disorder and alcohol dependence. Psilocybin is a naturally occurring psychedelic prodrug compound produced by more than 200 species of mushrooms. It is the active ingredient found in “magic” mushrooms, or “shrooms." Many people do not know that psychedelics can be life-changing tools! The misconception about psychedelics is that they are for people who just want to have a wild trip and get high, 1960's style. In fact, according to research, psilocybin has potential to treat a range of psychiatric and behavioral disorders. This includes depression, obsessive-compulsive disorder, quitting smoking, alcohol addiction, cocaine addiction, cluster headaches, and even cancer-related or other end-of-life psychological distress. Psychedelic compounds have often been maligned by mainstream society for their connection with recreational drug use. However, the body of evidence that these chemicals could be used to treat various mental health problems is growing along with investor interest, innovative start-ups and passionate activists. Recently Denver, Colorado and Oregon have had initiatives to decriminalize psilocybin mushrooms. Currently the mushrooms are a Schedule I drug according to the Drug Enforcement Administration. This is also the case for marijuana however, and the way marijuana has been getting a major push for legislation is what could be in store as well for psilocybin! Leveraging its newly formed health and wellness committee, RMANF will continue to actively pursue alpha generating investments within this flourishing sector. The global mushroom market accounted for US$38.13 billion in 2017 and is forecasted to expand at a CAGR of 7.9 per cent from 2018 to 2026. This growth will be further bolstered by the increasing demand for meat substitutes, as well as shifting consumer preference towards vegan foods.” Kevin Matthews, Advisory Board member and Chair of RMANF's Health and Wellness Committee stated: “We continue to be encouraged by the recent growth within the bourgeoning health and wellness vertical and are actively looking to deploy additional capital into promising, high growth companies. As a result of recent landmark legislative shifts, Roadman’s dedicated Health and Wellness committee is currently evaluating complimentary investments within the medicinal mushroom sector, with the objective of augmenting Champignon’s mushroom-extract-infused tea formulations”. Champignon has also begun advanced discussions with Canadian big box food retailers, as well as prominent wholesalers regarding brick and mortar distribution of its proprietary mushroom-infused tea formulations. The company forecasts it will achieve shelf-space for its inaugural SKUs in the third quarter of 2019 and is additionally working towards establishing a physical pop-up store in a Toronto Coffee shop in the coming months. RMANF CEO Luke Montaine has said, "We are excited that under our guidance and advisory. Champignon Brand’s inc. has been able to launch their new digital flagship store on schedule. Consumers are becoming more digitally engaged and this store will allow the company to sell it’s products globally and accelerate momentum on their strategy. Former Canopy Growth Corp. CEO Bruce Linton has went on to become a director at Mind Medicine, a Toronto-based company that is seeking to establish safe psychedelic-assisted treatments for mental illness. According to Linton, the opportunity for psychedelics as medicine as similar to the outlook for medicinal cannabis years ago! “There’s probably untapped value, which will only go to the people who are at the beginning and bold,” Linton has said in an interview. Recently RMANF announced that it has formed the Denver Psychedelic Summit” conference planning committee, which plans to host numerous high-profile industry leaders and will be held in Denver on the anniversary date of when the first US city decriminalized psilocybin mushrooms. Last year’s ballot initiative in Denver opened a new, grassroots front in the psychedelic renaissance and Roadman Investments wants to help support and be an integral part of that movement. The Committee will work to assemble the conference itinerary including the program sessions, organize speakers and venue to ensure a meaningful event for all attendees. Specific keynote speakers, program and location for the 2020 conference will be announced in the coming months. This conference will allow Roadman to find new opportunities to place capital into pioneering companies that are working towards helping people with depression and mental health problems with new breakthrough treatments. CEO and Director Luke Montaine stated: “Denver is becoming a major hub for psychedelics and it is the ideal location for this event. There are so many important developments taking place in this industry and our team is excited to help support the global psychedelic community.” While the world is buzzing about marijuana, psychedelics are not getting that much attention... This could be an opportunity at the very early stages and learning about what RMANF is doing and how big the mushroom industry is poised to get could be very beneficial to our readers. Add RMANF to your radar right away! The stock is trading around a nickel right now but who knows for how much longer as Wall Street begins to embrace what could be the new medical marijuana. Roadman Investments (OTC: RMANF) (TSXV: LITT) is our newest alert with mind blowing potential for upside so get ready! Sources: [ [( []( [( [( [( © 2019 PTE.la PTE, LLC (publisher of PTE.la) is NOT registered as an investment adviser nor a broker/dealer with either the U. S. Securities & Exchange Commission or any state securities regulatory authority. Users of this website are advised that all information presented on this website is solely for informational purposes, is not intended to be used as a personalized investment recommendation, and is not attuned to any specific portfolio or to any user's particular investment needs or objectives. Past performance is NOT indicative of future results. Furthermore, such information is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell (short or otherwise) any security. All users of this website must determine for themselves what specific investments to make or not make and are urged to consult with their own independent financial advisors with respect to any investment decision. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. All opinions, analyses and information included on this website are based on sources believed to be reliable and written in good faith, but should be independently verified, and no representation or warranty of any kind, express or implied, is made, including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. In addition, we undertake no responsibility to notify such opinions, analyses or information or to keep such opinions, analyses or information current. Also be aware that owners, employees and writers of and for PTE, LLC may have long or short positions in securities that may be discussed on this website or newsletter. Past results are not indicative of future profits. This table is accurate, though not every trade is represented. Profits and losses reported are simulated figures from virtual simulated portfolios. We are engaged in the business of advertising and promoting companies for monetary compensation. All content in our releases is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Neither the information presented nor any statement or expression of opinion, or any other matter herein, directly or indirectly constitutes a solicitation of the purchase or sale of any securities. PTE.la’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as are commendation by PTE.la or an offer or solicitation to buy or sell any security. Neither the owner of PTE.la nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with alicensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed in a release or on our website unless you can afford to lose your entire investment. Also, investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. To review our complete disclaimer and additional information, please visit . PTE.la makes no recommendation that the securities of the companies profiled or discussed in our releases or on our website should be purchased, sold or held by investors. PTE.la is owned and operated by PTE LLC. PTE LLC and has been compensated up to Fifteen-Thousand Dollars via wire transfer for a 1 Day Marketing campaign by a third party for emails regarding RMANF. Any compensation received by PTE LLC constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. A third party of PTE LLC may have shares and may liquidate, which may negatively affect the stock price. PTE LLC affiliates may at any time have a position in the securities mentioned herein and may increase or decrease such positions without notice which will negatively affect the market. Some of the content in this release contains forward - looking information within the meaning of Section 27 A of the Securities Act of 1 9 9 3 and Section 21 E of the Securities Exchange Act of 1 9 3 4 including statements regarding expected continual growth of the profiled company and the value of its securities. In accordance with the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 it is hereby noted that statements contained herein that look forward in time which include everything other than historical information, involve risk and uncertainties that may affect a company's actual results of operation. A company's actual performance could greatly differ from those described in any forward - looking statements or announcements mentioned in this release. Factors that should be considered that could cause actual results to differ include: the size and growth of the market for the company's products; the company's ability to fund its capital requirements in the near term and in the long term; pricing pressures; unforeseen and/or unexpected circumstances in happenings; etc. and the risk factors and other factors set forth in the company’s filings with the Securities and Exchange Commission. However, acompany’s past performance does not guarantee future results. Generally, the information regarding a company profiled is provided from public sources which we believe to be reliable but is not guaranteed by us as being accurate. Further specific financial information, filings and disclosures as well as general investor information about the profiled company, advice to investors and other investor resources are available at the Securities and Exchange Commission (“SEC”) website www.sec.gov and the Financial Industry Regulatory Authority (“FINRA”) website at www.finra.org. Any investment should be made only after consulting with a qualified investment advisor and reviewing the publicly available financial statement and other information about the company profiled and verifying that the investment is appropriate and suitable. PTE.la makes no representations, warranties or guarantees as to the accuracy or completeness of the information provided or discussed. Viewers should not rely solely on the information obtained in this release or on our website. 9 Downing street Newark NJ 07105 USA [Unsubscribe]( | [Change Subscriber Options](